August 11, 2025Frontiers in Bioengineering and BiotechnologyOpen Access

A light-controlled one-tube detection platform combining CRISPR-Cas12a and RPA: an innovative approach for rapid diagnosis of Acinetobacter baumannii

View Full Paper

Ask AI

Bookmark

The detection system achieves a limit of detection as low as 10 copies/μL, ensuring rapid identification of the pathogen.
High sensitivity and specificity were confirmed, with no cross-reactivity with six common pathogenic bacteria.
This one-tube method significantly reduces contamination risk by eliminating repeated tube opening during testing.
Clinical validation demonstrated consistent results with conventional PCR using 38 sputum samples, highlighting its reliability.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Innovative method combines CRISPR-Cas12a and RPA for rapid, sensitive diagnosis of A. baumannii, suggesting significant improvements in nosocomial infection management.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/68af269bcf1dd9ea359e2890 https://doi.org/10.3389/fbioe.2025.1663915

View Full Paper

Ask AI

Bookmark

Implication

Innovative method combines CRISPR-Cas12a and RPA for rapid, sensitive diagnosis of A. baumannii, suggesting significant improvements in nosocomial infection management.

A light-controlled one-tube detection platform combining CRISPR-Cas12a and RPA: an innovative approach for rapid diagnosis of Acinetobacter baumannii

Key Points

Discussion

Implication

Cite This Study

A light-controlled one-tube detection platform combining CRISPR-Cas12a and RPA: an innovative approach for rapid diagnosis of Acinetobacter baumannii

Key Points

Discussion

Implication

Cite This Study